Please login to the form below
endometriosis
This page shows the latest endometriosis news and features for those working in and with pharma, biotech and healthcare.
Mind the gender gap: how marcomms can tackle gender health inequality
For example, over a third of women are prescribed antidepressants for menopause, and reports of pain due to underlying endometriosis is too often missed and dismissed as ‘part of being a
Latest news
-
Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
Around 200 million women suffer from endometriosis worldwide and it can take between four to eleven years to get a diagnosis. ... Both studies met their co-primary endpoints, showing clinically significant reductions in menstrual pain and non-menstrual
-
Organon buys Forendo in $1bn deal
Forendo purchase bolsters Organon’s pipeline with candidates in endometriosis and polycystic ovarian syndrome. ... Endometriosis is among our highest priority areas of focus,” said Organon CEO, Kevin Ali.
-
Bayer bulks up in women’s health again with non-hormonal contraceptive deal
polycystic ovary syndrome (PCOS), extending their current partnership for endometriosis.
-
Bayer extends alliance with Evotec in women’s health
Bayer and Evotec have already been working together on drug candidates for endometriosis, and adding PCOS into the mix means that the collaboration is now addressing health conditions that affect up ... The lead candidate from the endometriosis
-
Myovant preps US filing for relugolix in prostate cancer
Myovant is in a head-to-head battle with AbbVie and its rival GnRH inhibitor Orilissa (elagolix) in endometriosis-related pain and uterine fibroids, but has a clear run at the ... Orilissa has been approved in endometriosis and filed for uterine
More from news
Approximately 2 fully matching, plus 29 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma companies to watch
Their performance in 2020, along with other new launches like Orilissa (elagolix) for endometriosis pain will be a signpost as to whether they can fulfil that potential.
-
Pharma deals during October 2012
Evotec / Bayer. 5 yr discovery, collaboration &licence. Three drug candidates for endometriosis.
-
Country report: The healthcare market in Brazil
AIDS, cancer, diabetes and less common conditions such as Chagas disease and endometriosis, covering around 400, 000 people.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
The implications of this, particularly in the future treatment of poorly understood conditions such as endometriosis, are extremely promising. ... Endometriosis. Published March 31, 2021. Accessed November 3, 2021. All Party Parliamentary Group on
-
New syndicated patient reports -
Living with Uterine Fibroids and Endometriosis US 2022. ... Living with Uterine Fibroids (UF) and Endometriosis (Endo) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition,
-
Bridging the gender health gap: 9 key takeaways from Thrive’s webinar on tech and women's health
like polycystic ovary syndrome and endometriosis.
-
Women’s 2021 health wins worth celebrating
Scotland has made headway however in starting to bridge this gap, by launching the first Women’s Health Plan with a focus on improving endometriosis diagnosis, miscarriage support, menopause services and
-
How femtech is changing the future of women's health
can. Femtech innovations in reproductive health, endometriosis, contraception, menopause and women’s mental health have had success in clinical trials and won millions of global supporters.
More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
